Fact CheckerSign in

NCT07591844Completed

Effect of Periodontal Therapy on Asprosin in Stable Angina

Effect of Non-Surgical Periodontal Therapy on Serum Asprosin in Patients With Stable Angina

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

This study aims to evaluate the effect of non-surgical periodontal therapy on serum asprosin levels in patients with stable angina and periodontitis. Asprosin is a novel metabolic biomarker reported to have potential protective roles in cardiovascular diseases and inflammatory processes. The study also investigates the relationship between periodontal parameters and serum asprosin levels before and after periodontal therapy.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
11 May 2026
Start date
20 May 2026
Primary completion date
20 Aug 2026
Lead sponsor
Ondokuz Mayıs University
NCT number
NCT07591844

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 20 May 2026 to the primary completion date, 20 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Use of local or systemic antibiotics for the treatment of widespread infection within the past 3 months
  • History of acute myocardial infarction within the past 6 months

Age

  • Age under 18 years

Other

  • Unwillingness to participate in the study or to provide informed consent
  • Receipt of periodontal treatment within the past 6 months
  • Pregnancy or lactation (for female participants)

Who the study is looking for

  • Willingness to participate in the study and provide written informed consent
  • Age 18 years or older
  • No periodontal treatment within the past 6 months
  • No use of local or systemic antibiotics within the past 3 months

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ondokuz Mayis University
Coordinator of this site? Confirm its status
SamsunTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.